Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

Abivax will present nine scientific abstracts on obefazimod at Digestive [...]

Alto Neuroscience has started a Phase 2b trial of ALTO-207 [...]

ARTCLINE has completed patient enrolment in a 142-patient randomized study [...]

Neomorph has closed a $100 million Series B financing to [...]

Kainova Therapeutics has dosed the first European patient in its [...]

Click Therapeutics has secured a $50M Series D investment from [...]

Kainova Therapeutics has dosed the first patient in Europe in [...]

START has appointed Salwan Al Mutar as director of clinical [...]

Life Biosciences has raised $80m in a Series D financing [...]